GLAXOSMITHKLINE PHARMACEUTICALGLAXOSMITHKLINE PHARMACEUTICALGLAXOSMITHKLINE PHARMACEUTICAL

GLAXOSMITHKLINE PHARMACEUTICAL

No trades
See on Supercharts

GLAXO fundamentals

GLAXOSMITHKLINE PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of GLAXO for the last quarter is 10.11 B INR, and it's 24.07% higher compared to the previous quarter. The net income of Q2 24 is 2.52 B INR.

Q4 '07
Q4 '08
Q4 '09
Q4 '10
Q4 '11
Q4 '12
Q4 '13
Q1 '18
Q2 '18
Q3 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: INR
Q4 '07
Q4 '08
Q4 '09
Q4 '10
Q4 '11
Q4 '12
Q4 '13
Q1 '18
Q2 '18
Q3 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth